Kiniksa Pharmaceuticals International (KNSA) Tax Rate (2017 - 2026)
Kiniksa Pharmaceuticals International's (KNSA) quarterly Tax Rate came in at 18.34% in Q2 2026, down 371.0% YoY from 6.77% in Q2 2025, and down 40.58% on a QoQ basis from 30.87% in Q1 2026.
Kiniksa Pharmaceuticals International (KNSA) Tax Rate (2017 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International (KNSA) has 10 years of Tax Rate data on file, last reported at 18.34% in Q2 2026.
- Quarterly Tax Rate fell 371.0% year-over-year to 18.34% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 29.4% (down 3701.0% YoY) and the FY2025 annual result came in at 33.6%, up 5308.0% from the prior year.
- Tax Rate declined to 18.34% in Q2 2026, from 30.87% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 1308.39% in Q2 2023 to a low of 379.5% in Q3 2022.
- A 5-year average of 70.09% and a median of 20.2% in 2026 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2023 — Tax Rate jumped 131211 bps — and 2024, when it plunged 103878 bps.
- Tracing KNSA's Tax Rate over 5 years: stood at 2.62% in 2022, then surged by 1108 bps to 31.63% in 2023, then surged by 51 bps to 47.65% in 2024, then fell by 18 bps to 38.98% in 2025, then plunged by 53 bps to 18.34% in 2026.
- The last three Tax Rate figures came in at 18.34% (Q2 2026), 30.87% (Q1 2026), and 38.98% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -26.59% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -30.40% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 10.65% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -85.63% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 10.97% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.57% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Kiniksa Pharmaceuticals International | 6.09 Bn | 5.57 Bn | 220.03 Mn | 18.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.34% |
| Jun 30, 2026 | 18.34% |
| Jun 30, 2026 | 18.34% |
| Mar 31, 2026 | 30.87% |
| Mar 31, 2026 | 30.87% |
| Mar 31, 2026 | 30.87% |
| Dec 31, 2025 | 38.98% |
| Dec 31, 2025 | 38.98% |
| Dec 31, 2025 | 38.98% |
| Sep 30, 2025 | 32.12% |
| Sep 30, 2025 | 32.12% |
| Sep 30, 2025 | 32.12% |
| Jun 30, 2025 | 22.05% |
| Jun 30, 2025 | 22.05% |
| Jun 30, 2025 | 22.05% |
| Mar 31, 2025 | 45.14% |
| Mar 31, 2025 | 45.14% |
| Mar 31, 2025 | 45.14% |
| Dec 31, 2024 | 47.65% |
| Dec 31, 2024 | 47.65% |